Skip to Main Content

Author Details

Jennifer B Permuth
Moffitt Cancer Center
2004
100
34
PMIDPaper TitleJournal TitlePublished Year
36209796Prospective, Multi-Institutional, Real-Time Next-Generation Sequencing of Pancreatic Cyst Fluid Reveals Diverse Genomic Alterations That Improve the Clinical Management of Pancreatic Cysts.Gastroenterology2023
36209796Prospective, Multi-Institutional, Real-Time Next-Generation Sequencing of Pancreatic Cyst Fluid Reveals Diverse Genomic Alterations That Improve the Clinical Management of Pancreatic Cysts.Gastroenterology2023
36817179Pancreatic colloid adenocarcinoma arising from intraductal papillary mucinous neoplasm: Radiologic-pathologic correlation with cinematic rendering.Acta Radiol Open2023
36879667The impact of age and comorbidity on localized pancreatic cancer outcomes: A US retrospective cohort analysis with implications for surgical centralization.Surg Open Sci2023
37310397A call for standardized reporting of early-onset colorectal peritoneal metastases.Eur J Cancer Prev2023
37358854Association of Age With Treatment-Related Adverse Events and Survival in Patients With Metastatic Colorectal Cancer.JAMA Netw Open2023
36454217A pilot study to evaluate tissue- and plasma-based DNA driver mutations in a cohort of patients with pancreatic intraductal papillary mucinous neoplasms.G3 (Bethesda)2023
37310397A call for standardized reporting of early-onset colorectal peritoneal metastases.Eur J Cancer Prev2023
37358854Association of Age With Treatment-Related Adverse Events and Survival in Patients With Metastatic Colorectal Cancer.JAMA Netw Open2023
36817179Pancreatic colloid adenocarcinoma arising from intraductal papillary mucinous neoplasm: Radiologic-pathologic correlation with cinematic rendering.Acta Radiol Open2023
36879667The impact of age and comorbidity on localized pancreatic cancer outcomes: A US retrospective cohort analysis with implications for surgical centralization.Surg Open Sci2023
36454217A pilot study to evaluate tissue- and plasma-based DNA driver mutations in a cohort of patients with pancreatic intraductal papillary mucinous neoplasms.G3 (Bethesda)2023
34965383Functional analysis of the 1p34.3 risk locus implicates GNL2 in high-grade serous ovarian cancer.Am J Hum Genet2022
35513007A Path Forward for Understanding and Addressing Multifaceted Pancreatic Cancer Disparities.Gastroenterology2022
35445726Pancreatic Ductal Carcinoma Risk Associated With Hereditary Cancer-Risk Genes.J Natl Cancer Inst2022
35565354Copy Number Alterations as Novel Biomarkers and Therapeutic Targets in Colorectal Cancer.Cancers (Basel)2022
35491771A pilot study to troubleshoot quality control metrics when assessing circulating miRNA expression data reproducibility across study sites.Cancer Biomark2022
35869601Safe performance of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in patients with HIV infection.Cancer Rep (Hoboken)2022
36332889A comparative Proteomics Analysis Identified Differentially Expressed Proteins in Pancreatic Cancer-Associated Stellate Cell Small Extracellular Vesicles.Mol Cell Proteomics2022
36199487Hospital Surgical Volume Is Poorly Correlated With Delivery of Multimodal Treatment for Localized Pancreatic Cancer: A National Retrospective Cohort Study.Ann Surg Open2022
35986871Patient-caregiver dyads in pancreatic cancer: identification of patient and caregiver factors associated with caregiver well-being.J Behav Med2022
35320814Core Homologous Recombination Mutations and Improved Survival in Nonpancreatic GI Cancers.Am J Clin Oncol2022
35274712BRAF Mutations Are Associated with Poor Survival Outcomes in Advanced-stage Mismatch Repair-deficient/Microsatellite High Colorectal Cancer.Oncologist2022
34965383Functional analysis of the 1p34.3 risk locus implicates GNL2 in high-grade serous ovarian cancer.Am J Hum Genet2022
35491771A pilot study to troubleshoot quality control metrics when assessing circulating miRNA expression data reproducibility across study sites.Cancer Biomark2022
35565354Copy Number Alterations as Novel Biomarkers and Therapeutic Targets in Colorectal Cancer.Cancers (Basel)2022
35513007A Path Forward for Understanding and Addressing Multifaceted Pancreatic Cancer Disparities.Gastroenterology2022
35445726Pancreatic Ductal Carcinoma Risk Associated With Hereditary Cancer-Risk Genes.J Natl Cancer Inst2022
35869601Safe performance of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in patients with HIV infection.Cancer Rep (Hoboken)2022
36332889A comparative Proteomics Analysis Identified Differentially Expressed Proteins in Pancreatic Cancer-Associated Stellate Cell Small Extracellular Vesicles.Mol Cell Proteomics2022
36199487Hospital Surgical Volume Is Poorly Correlated With Delivery of Multimodal Treatment for Localized Pancreatic Cancer: A National Retrospective Cohort Study.Ann Surg Open2022
35986871Patient-caregiver dyads in pancreatic cancer: identification of patient and caregiver factors associated with caregiver well-being.J Behav Med2022
35320814Core Homologous Recombination Mutations and Improved Survival in Nonpancreatic GI Cancers.Am J Clin Oncol2022
35274712BRAF Mutations Are Associated with Poor Survival Outcomes in Advanced-stage Mismatch Repair-deficient/Microsatellite High Colorectal Cancer.Oncologist2022
32546565Population-based targeted sequencing of 54 candidate genes identifies <i>PALB2</i> as a susceptibility gene for high-grade serous ovarian cancer.J Med Genet2021
31851004The Impact of Socioeconomic Deprivation on Clinical Outcomes for Pancreatic Adenocarcinoma at a High-volume Cancer Center: A Retrospective Cohort Analysis.Ann Surg2021
33671939The Florida Pancreas Collaborative Next-Generation Biobank: Infrastructure to Reduce Disparities and Improve Survival for a Diverse Cohort of Patients with Pancreatic Cancer.Cancers (Basel)2021
34140011Morphologic and molecular correlates of EZH2 as a predictor of platinum resistance in high-grade ovarian serous carcinoma.BMC Cancer2021
32546565Population-based targeted sequencing of 54 candidate genes identifies <i>PALB2</i> as a susceptibility gene for high-grade serous ovarian cancer.J Med Genet2021
33037322Establishing a living biobank of patient-derived organoids of intraductal papillary mucinous neoplasms of the pancreas.Lab Invest2021
33415559Neoadjuvant Chemotherapy for Intrahepatic Cholangiocarcinoma: A Propensity Score Survival Analysis Supporting Use in Patients with High-Risk Disease.Ann Surg Oncol2021
33436325Rare Germline Variants in ATM Predispose to Prostate Cancer: A PRACTICAL Consortium Study.Eur Urol Oncol2021
34901696A Case Control Study of the Seroprevalence of <i>Helicobacter pylori</i> Proteins and Their Association with Pancreatic Cancer Risk.J Pancreat Cancer2021
34367997Comparison of Radiomic Features in a Diverse Cohort of Patients With Pancreatic Ductal Adenocarcinomas.Front Oncol2021
34813586Utilizing digital pathology to quantify stromal caveolin-1 expression in malignant and benign ovarian tumors: Associations with clinicopathological parameters and clinical outcomes.PLoS One2021
33671939The Florida Pancreas Collaborative Next-Generation Biobank: Infrastructure to Reduce Disparities and Improve Survival for a Diverse Cohort of Patients with Pancreatic Cancer.Cancers (Basel)2021
34901696A Case Control Study of the Seroprevalence of <i>Helicobacter pylori</i> Proteins and Their Association with Pancreatic Cancer Risk.J Pancreat Cancer2021
34813586Utilizing digital pathology to quantify stromal caveolin-1 expression in malignant and benign ovarian tumors: Associations with clinicopathological parameters and clinical outcomes.PLoS One2021
34140011Morphologic and molecular correlates of EZH2 as a predictor of platinum resistance in high-grade ovarian serous carcinoma.BMC Cancer2021
34367997Comparison of Radiomic Features in a Diverse Cohort of Patients With Pancreatic Ductal Adenocarcinomas.Front Oncol2021
  • 1 - 50 of 200

Recommended Authors

Derek S Chiu
University of British Columbia, and Vancouver General Hospital
Career Start Year 2016
Number of shared co-authors 70
Osvaldo Espin-Garcia
Princess Margaret Cancer Centre, University Health Network
Career Start Year 2013
Number of shared co-authors 2
Ashton A Connor
Houston Methodist Hospital
Career Start Year 2012
Number of shared co-authors 5
Chen Wang
Center for Individualized Medicine, Mayo Clinic
Career Start Year 2011
Number of shared co-authors 105
Gun Ho Jang
Ontario Institute for Cancer Research
Career Start Year 2011
Number of shared co-authors 4
Guanglong Jiang
Indiana University School of Medicine
Career Start Year 2011
Number of shared co-authors 0
Daniel J Serie
Mayo Clinic
Career Start Year 2010
Number of shared co-authors 32
Amber L Johns
Garvan Institute of Medical Research and The Kinghorn Cancer Centre
Career Start Year 2009
Number of shared co-authors 4
Salvatore Piscuoglio
University of Basel
Career Start Year 2008
Number of shared co-authors 4
Eric C Polley
Mayo Clinic
Career Start Year 2007
Number of shared co-authors 49
Nicola Waddell
QIMR Berghofer Medical Research Institute
Career Start Year 2006
Number of shared co-authors 42
Albrecht Stenzinger
Institute of Pathology, University Hospital Heidelberg
Career Start Year 2005
Number of shared co-authors 6
Joshy George
Peter MacCallum Cancer Centre
Career Start Year 2005
Number of shared co-authors 80
Hisani N Horne
National Cancer Institute
Career Start Year 2004
Number of shared co-authors 30
Andrew H Beck
Beth Israel Deaconess Medical Center, Harvard Medical School
Career Start Year 2004
Number of shared co-authors 51
Leslie Cope
Johns Hopkins University School of Medicine
Career Start Year 2003
Number of shared co-authors 5
Olivier Harismendy
University of California
Career Start Year 2003
Number of shared co-authors 3
Michael Slifker
Fox Chase Cancer Center
Career Start Year 2002
Number of shared co-authors 0
Pingfu Fu
Case Western Reserve University
Career Start Year 2000
Number of shared co-authors 24
Steve E Kalloger
University of British Columbia
Career Start Year 2000
Number of shared co-authors 20
Richard B Schwab
Department of Medicine and Moores Cancer Center, University of California San Diego
Career Start Year 2000
Number of shared co-authors 3
Eric A Collisson
University of California san francisco
Career Start Year 1999
Number of shared co-authors 3
Franklin W Huang
Institute for Human Genetics, University of California san francisco
Career Start Year 1998
Number of shared co-authors 10
Jan Budczies
Institute of Pathology, University Hospital Heidelberg
Career Start Year 1996
Number of shared co-authors 4
Hidewaki Nakagawa
RIKEN Center for Integrative Medical Sciences
Career Start Year 1994
Number of shared co-authors 43
Anirban Maitra
The University of Texas MD Anderson Cancer Center
Career Start Year 1993
Number of shared co-authors 10
Sudhir Srivastava
National Cancer Institute
Career Start Year 1992
Number of shared co-authors 8
Wei Xu
Princess Margaret Cancer Centre
Career Start Year 1991
Number of shared co-authors 12
Aaron Pollett
Mount Sinai Hospital
Career Start Year 1990
Number of shared co-authors 9
Luigi Marchionni
Weill-Cornell School of Medicine
Career Start Year 1989
Number of shared co-authors 1

Collaborators

Ellen L Goode
Mayo Clinic College of Medicine
Co-authored papers 34
Joellen M Schildkraut
Rollins School of Public Health, Emory University
Co-authored papers 33
Paul D P Pharoah
Center for Cancer Genetic Epidemiology, University of Cambridge
Co-authored papers 29
Simon A Gayther
Cedars-Sinai Medical Center
Co-authored papers 28
Andrew Berchuck
Duke School of Medicine
Co-authored papers 27
Susan J Ramus
School of Clinical Medicine, University of NSW Sydney, Lowy Cancer Research Centre
Co-authored papers 26
Honglin Song
University of Cambridge
Co-authored papers 25
Mary Anne Rossing
Fred Hutchinson Cancer Research Center
Co-authored papers 24
Brooke L Fridley
H. Lee Moffitt Cancer Center and Research Institute
Co-authored papers 24
Jonathan Tyrer
Co-authored papers 24
Nicolas Wentzensen
National Cancer Institute, National Institutes of Health
Co-authored papers 24
Jennifer A Doherty
Huntsman Cancer Institute, University of Utah
Co-authored papers 24
Usha Menon
College of Nursing, University of South Florida
Co-authored papers 23
Alvaro N A Monteiro
H. Lee Moffitt Cancer Center & Research Institute
Co-authored papers 23
Anna H Wu
University of Southern California
Co-authored papers 23
Celeste Leigh Pearce
University of Michigan School of Public Health ann arbor
Co-authored papers 23
Jenny Chang-Claude
German Cancer Research Center (DKFZ)
Co-authored papers 22
Aleksandra Gentry-Maharaj
UCL EGA Institute for Women's Health, University College London
Co-authored papers 22
Douglas F Easton
University of Cambridge
Co-authored papers 22
Jacek Gronwald
International Hereditary Cancer Center, Pomeranian Medical University
Co-authored papers 22
Douglas A Levine
Perlmutter Cancer Center
Co-authored papers 22
Hoda Anton-Culver
University of California irvine
Co-authored papers 22
Beth Y Karlan
David Geffen School of Medicine, University of California los angeles
Co-authored papers 22
Marc T Goodman
Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center
Co-authored papers 22
Tanja Pejovic
Oregon Health & Science University
Co-authored papers 21
Wei Zheng
Co-authored papers 21
Elisa V Bandera
Co-authored papers 21
Graham G Giles
Co-authored papers 20
Ian G Campbell
Co-authored papers 20
Jolanta Lissowska
The M. Sklodowska-Curie Cancer Center and Institute of Oncology
Co-authored papers 20
Release 1.2